Anika Therapeutics, Inc. (ANIK)
USD 14.13
(-3.81%)
USD 14.13
(-3.81%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 103.08 Million USD | 10.16% |
| 2022 | 93.57 Million USD | 12.82% |
| 2021 | 82.94 Million USD | 20.16% |
| 2020 | 69.02 Million USD | -19.61% |
| 2019 | 85.86 Million USD | 15.6% |
| 2018 | 74.27 Million USD | -13.69% |
| 2017 | 86.05 Million USD | 8.45% |
| 2016 | 79.35 Million USD | 10.29% |
| 2015 | 71.94 Million USD | -15.02% |
| 2014 | 84.66 Million USD | 61.83% |
| 2013 | 52.31 Million USD | 23.47% |
| 2012 | 42.36 Million USD | 11.51% |
| 2011 | 37.99 Million USD | 19.74% |
| 2010 | 31.72 Million USD | 19.89% |
| 2009 | 26.46 Million USD | 17.15% |
| 2008 | 22.59 Million USD | 19.22% |
| 2007 | 18.94 Million USD | 20.52% |
| 2006 | 15.72 Million USD | -15.88% |
| 2005 | 18.69 Million USD | 13.16% |
| 2004 | 16.51 Million USD | 123.23% |
| 2003 | 7.39 Million USD | 45.7% |
| 2002 | 5.07 Million USD | 64.71% |
| 2001 | 3.08 Million USD | -59.76% |
| 2000 | 7.66 Million USD | -6.56% |
| 1999 | 8.2 Million USD | -5.75% |
| 1998 | 8.7 Million USD | 14.47% |
| 1997 | 7.6 Million USD | 1420.0% |
| 1996 | 500 Thousand USD | -16.67% |
| 1995 | 600 Thousand USD | -40.0% |
| 1994 | 1 Million USD | 233.33% |
| 1993 | 300 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 24.62 Million USD | -6.46% |
| 2024 Q2 | 27.36 Million USD | 11.11% |
| 2024 Q3 | 1.44 Million USD | -94.74% |
| 2023 FY | 103.08 Million USD | 10.16% |
| 2023 Q1 | 22.84 Million USD | -5.34% |
| 2023 Q2 | 28.97 Million USD | 26.83% |
| 2023 Q4 | 26.32 Million USD | 5.55% |
| 2023 Q3 | 24.94 Million USD | -13.9% |
| 2022 Q1 | 21.8 Million USD | 20.24% |
| 2022 Q2 | 24.86 Million USD | 14.02% |
| 2022 FY | 93.57 Million USD | 12.82% |
| 2022 Q3 | 22.77 Million USD | -8.38% |
| 2022 Q4 | 24.13 Million USD | 5.94% |
| 2021 Q2 | 20.81 Million USD | -0.77% |
| 2021 FY | 82.94 Million USD | 20.16% |
| 2021 Q4 | 18.13 Million USD | -21.24% |
| 2021 Q1 | 20.97 Million USD | 25.26% |
| 2021 Q3 | 23.02 Million USD | 10.62% |
| 2020 FY | 69.02 Million USD | -19.61% |
| 2020 Q1 | 21.19 Million USD | 0.35% |
| 2020 Q2 | 13.74 Million USD | -35.17% |
| 2020 Q4 | 16.74 Million USD | -3.45% |
| 2020 Q3 | 17.34 Million USD | 26.2% |
| 2019 FY | 85.86 Million USD | 15.6% |
| 2019 Q1 | 17.41 Million USD | -12.74% |
| 2019 Q2 | 23.58 Million USD | 35.44% |
| 2019 Q3 | 23.74 Million USD | 0.7% |
| 2019 Q4 | 21.12 Million USD | -11.05% |
| 2018 FY | 74.27 Million USD | -13.69% |
| 2018 Q4 | 19.95 Million USD | 7.84% |
| 2018 Q1 | 13.41 Million USD | -35.09% |
| 2018 Q3 | 18.5 Million USD | -17.37% |
| 2018 Q2 | 22.39 Million USD | 66.9% |
| 2017 Q4 | 20.67 Million USD | -1.25% |
| 2017 Q2 | 27.14 Million USD | 56.89% |
| 2017 Q1 | 17.3 Million USD | -18.33% |
| 2017 Q3 | 20.93 Million USD | -22.89% |
| 2017 FY | 86.05 Million USD | 8.45% |
| 2016 FY | 79.35 Million USD | 10.29% |
| 2016 Q4 | 21.18 Million USD | 1.9% |
| 2016 Q3 | 20.79 Million USD | 1.34% |
| 2016 Q2 | 20.51 Million USD | 21.7% |
| 2016 Q1 | 16.85 Million USD | -31.48% |
| 2015 Q4 | 24.6 Million USD | 32.95% |
| 2015 Q2 | 17.62 Million USD | 57.31% |
| 2015 Q1 | 11.2 Million USD | -36.84% |
| 2015 FY | 71.94 Million USD | -15.02% |
| 2015 Q3 | 18.5 Million USD | 4.97% |
| 2014 Q4 | 17.74 Million USD | 8.65% |
| 2014 Q3 | 16.33 Million USD | -22.02% |
| 2014 FY | 84.66 Million USD | 61.83% |
| 2014 Q1 | 29.64 Million USD | 97.45% |
| 2014 Q2 | 20.94 Million USD | -29.37% |
| 2013 FY | 52.31 Million USD | 23.47% |
| 2013 Q4 | 15.01 Million USD | 21.32% |
| 2013 Q3 | 12.37 Million USD | -14.74% |
| 2013 Q2 | 14.51 Million USD | 39.51% |
| 2013 Q1 | 10.4 Million USD | -32.15% |
| 2012 Q1 | 7.94 Million USD | -29.77% |
| 2012 Q4 | 15.33 Million USD | 103.25% |
| 2012 FY | 42.36 Million USD | 11.51% |
| 2012 Q3 | 7.54 Million USD | -34.62% |
| 2012 Q2 | 11.54 Million USD | 45.22% |
| 2011 Q1 | 6.13 Million USD | -23.52% |
| 2011 Q4 | 11.31 Million USD | 2.3% |
| 2011 FY | 37.99 Million USD | 19.74% |
| 2011 Q2 | 9.48 Million USD | 54.65% |
| 2011 Q3 | 11.06 Million USD | 16.61% |
| 2010 FY | 31.72 Million USD | 19.89% |
| 2010 Q3 | 7.76 Million USD | -9.84% |
| 2010 Q2 | 8.6 Million USD | 17.24% |
| 2010 Q4 | 8.01 Million USD | 3.33% |
| 2010 Q1 | 7.34 Million USD | 4.8% |
| 2009 Q2 | 6.22 Million USD | 4.02% |
| 2009 Q1 | 5.98 Million USD | -2.51% |
| 2009 FY | 26.46 Million USD | 17.15% |
| 2009 Q3 | 7.24 Million USD | 16.24% |
| 2009 Q4 | 7 Million USD | -3.25% |
| 2008 Q1 | 5.33 Million USD | -16.69% |
| 2008 Q4 | 6.14 Million USD | 7.77% |
| 2008 Q3 | 5.7 Million USD | 5.25% |
| 2008 FY | 22.59 Million USD | 19.22% |
| 2008 Q2 | 5.41 Million USD | 1.56% |
| 2007 Q2 | 4.07 Million USD | 11.81% |
| 2007 FY | 18.94 Million USD | 20.52% |
| 2007 Q4 | 6.4 Million USD | 32.6% |
| 2007 Q3 | 4.82 Million USD | 18.43% |
| 2007 Q1 | 3.64 Million USD | 28.58% |
| 2006 Q2 | 4.9 Million USD | 25.66% |
| 2006 Q4 | 2.83 Million USD | -30.44% |
| 2006 Q3 | 4.07 Million USD | -16.94% |
| 2006 Q1 | 3.9 Million USD | 22.04% |
| 2006 FY | 15.72 Million USD | -15.88% |
| 2005 FY | 18.69 Million USD | 13.16% |
| 2005 Q4 | 3.2 Million USD | -49.13% |
| 2005 Q3 | 6.29 Million USD | 28.31% |
| 2005 Q2 | 4.9 Million USD | 14.1% |
| 2005 Q1 | 4.29 Million USD | -19.24% |
| 2004 Q2 | 3.82 Million USD | 11.7% |
| 2004 FY | 16.51 Million USD | 123.23% |
| 2004 Q4 | 5.32 Million USD | 34.5% |
| 2004 Q3 | 3.95 Million USD | 3.56% |
| 2004 Q1 | 3.42 Million USD | 24.18% |
| 2003 Q1 | 1.41 Million USD | -42.38% |
| 2003 FY | 7.39 Million USD | 45.7% |
| 2003 Q4 | 2.75 Million USD | 56.66% |
| 2003 Q3 | 1.75 Million USD | 19.43% |
| 2003 Q2 | 1.47 Million USD | 4.03% |
| 2002 Q3 | 1.1 Million USD | -9.76% |
| 2002 FY | 5.07 Million USD | 64.71% |
| 2002 Q1 | 302.3 Thousand USD | -80.66% |
| 2002 Q2 | 1.21 Million USD | 303.42% |
| 2002 Q4 | 2.45 Million USD | 123.13% |
| 2001 FY | 3.08 Million USD | -59.76% |
| 2001 Q4 | 1.56 Million USD | 212.55% |
| 2001 Q3 | 500.19 Thousand USD | -38.25% |
| 2001 Q1 | 433.93 Thousand USD | -89.18% |
| 2001 Q2 | 809.98 Thousand USD | 86.66% |
| 2000 Q4 | 4.01 Million USD | 2124.25% |
| 2000 FY | 7.66 Million USD | -6.56% |
| 2000 Q3 | 180.29 Thousand USD | -89.34% |
| 2000 Q2 | 1.69 Million USD | -4.97% |
| 2000 Q1 | 1.78 Million USD | -22.6% |
| 1999 Q3 | 1.9 Million USD | -13.64% |
| 1999 Q2 | 2.2 Million USD | 22.22% |
| 1999 FY | 8.2 Million USD | -5.75% |
| 1999 Q1 | 1.8 Million USD | -10.0% |
| 1999 Q4 | 2.3 Million USD | 21.05% |
| 1998 Q2 | 3.2 Million USD | 113.33% |
| 1998 Q3 | 2 Million USD | -37.5% |
| 1998 Q4 | 2 Million USD | 0.0% |
| 1998 Q1 | 1.5 Million USD | -65.91% |
| 1998 FY | 8.7 Million USD | 14.47% |
| 1997 Q1 | 1 Million USD | 233.33% |
| 1997 Q3 | 800 Thousand USD | -42.86% |
| 1997 FY | 7.6 Million USD | 1420.0% |
| 1997 Q2 | 1.4 Million USD | 40.0% |
| 1997 Q4 | 4.4 Million USD | 450.0% |
| 1996 Q4 | 300 Thousand USD | -40.0% |
| 1996 Q3 | 500 Thousand USD | 66.67% |
| 1996 Q2 | 300 Thousand USD | 400.0% |
| 1996 Q1 | -100 Thousand USD | -150.0% |
| 1996 FY | 500 Thousand USD | -16.67% |
| 1995 FY | 600 Thousand USD | -40.0% |
| 1995 Q2 | 100 Thousand USD | -75.0% |
| 1995 Q4 | 200 Thousand USD | 200.0% |
| 1995 Q3 | -200 Thousand USD | -300.0% |
| 1995 Q1 | 400 Thousand USD | 100.0% |
| 1994 Q2 | 100 Thousand USD | -75.0% |
| 1994 Q4 | 200 Thousand USD | 0.0% |
| 1994 Q3 | 200 Thousand USD | 100.0% |
| 1994 FY | 1 Million USD | 233.33% |
| 1994 Q1 | 400 Thousand USD | 0.0% |
| 1993 FY | 300 Thousand USD | 0.0% |
| 1993 Q3 | 1.3 Million USD | 533.33% |
| 1993 Q2 | -300 Thousand USD | 0.0% |
| 1993 Q4 | 400 Thousand USD | -69.23% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -3942.667% |
| BrainsWay Ltd. | 23.09 Million USD | -346.442% |
| Cerus Corporation | 86.4 Million USD | -19.315% |
| Envoy Medical, Inc. | -473 Thousand USD | 21894.503% |
| electroCore, Inc. | 13.22 Million USD | -679.434% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -168896.721% |
| IceCure Medical Ltd | 1.3 Million USD | -7829.846% |
| Inogen, Inc. | 126.69 Million USD | 18.636% |
| OrthoPediatrics Corp. | 111.25 Million USD | 7.339% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 1803.934% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 217879.28% |
| MaxCyte, Inc. | 36.54 Million USD | -182.077% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -22481.415% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -121094.451% |
| Orthofix Medical Inc. | 486.27 Million USD | 78.8% |
| PAVmed Inc | -3.96 Million USD | 2697.984% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 1979.453% |
| RxSight, Inc. | 53.76 Million USD | -91.738% |
| Sight Sciences, Inc. | 69.17 Million USD | -49.025% |
| SI-BONE, Inc. | 109.42 Million USD | 5.787% |
| TELA Bio, Inc. | 40.11 Million USD | -157.0% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 32.151% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -1146.379% |
| Acutus Medical, Inc. | -3.13 Million USD | 3386.197% |
| Talis Biomedical Corporation | 371 Thousand USD | -27686.523% |
| Spectral AI, Inc. | 7.88 Million USD | -1208.223% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 1663.835% |
| CVRx, Inc. | 33.03 Million USD | -212.019% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -13839.74% |
| Bioventus Inc. | 328.19 Million USD | 68.589% |
| Venus Concept Inc. | 52.16 Million USD | -97.612% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | -548.108% |
| LivaNova PLC | 771.25 Million USD | 86.634% |
| 908 Devices Inc. | 25.32 Million USD | -307.108% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 66.768% |
| Nemaura Medical Inc. | -1.47 Million USD | 7082.427% |
| NeuroPace, Inc. | 48.12 Million USD | -114.222% |
| LENSAR, Inc. | 21.1 Million USD | -388.407% |
| Apyx Medical Corporation | 14.12 Million USD | -629.982% |
| Cutera, Inc. | 41.49 Million USD | -148.441% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | -458.41% |
| BioSig Technologies, Inc. | 18 Thousand USD | -572611.111% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | -657.221% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 88.396% |
| Axonics, Inc. | 274.55 Million USD | 62.453% |
| Outset Medical, Inc. | 29 Million USD | -255.476% |
| IRIDEX Corporation | 21.8 Million USD | -372.729% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | -45.094% |
| IRadimed Corporation | 50.15 Million USD | -105.525% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -35819.164% |
| INVO Bioscience, Inc. | 1.08 Million USD | -9391.243% |
| Telesis Bio, Inc. | 16.95 Million USD | -508.189% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 8.596% |
| Varex Imaging Corporation | 256.9 Million USD | 59.872% |
| Quipt Home Medical Corp. | 163.84 Million USD | 37.082% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 25491.133% |
| Pulmonx Corporation | 50.75 Million USD | -103.121% |
| Dynatronics Corporation | 7.63 Million USD | -1250.207% |
| Modular Medical, Inc. | -768 Thousand USD | 13522.917% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -1758.111% |
| Semler Scientific, Inc. | 61.2 Million USD | -68.444% |
| InMode Ltd. | 411.34 Million USD | 74.938% |
| Bruker Corporation | 1.51 Billion USD | 93.204% |
| Cytosorbents Corporation | 22.39 Million USD | -360.378% |
| DexCom, Inc. | 2.28 Billion USD | 95.496% |
| Align Technology, Inc. | 2.71 Billion USD | 96.208% |
| Viveve Medical, Inc. | 620 Thousand USD | -16527.097% |
| ZimVie Inc. | 290.38 Million USD | 64.499% |
| Movano Inc. | -158 Thousand USD | 65345.57% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 5.792% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -121094.451% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 71.963% |
| Profound Medical Corp. | 4.51 Million USD | -2183.729% |
| Insulet Corporation | 1.15 Billion USD | 91.112% |
| enVVeno Medical Corporation | -546 Thousand USD | 18980.586% |
| Surmodics, Inc. | 93.05 Million USD | -10.785% |
| iCAD, Inc. | 14.53 Million USD | -609.191% |
| Nuwellis, Inc. | 4.98 Million USD | -1968.794% |
| Biotricity, Inc. | 8.35 Million USD | -1133.659% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 68.931% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 28810.762% |
| InspireMD, Inc. | 1.8 Million USD | -5604.925% |
| PAVmed Inc. | -3.96 Million USD | 2697.984% |
| BIOLASE, Inc. | 16.72 Million USD | -516.408% |
| Beyond Air, Inc. | -1.3 Million USD | 7987.376% |
| FONAR Corporation | 45.14 Million USD | -128.374% |
| AxoGen, Inc. | 127.87 Million USD | 19.383% |
| Vivani Medical, Inc. | -357 Thousand USD | 28976.19% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 47.17% |
| Inari Medical, Inc. | 434.56 Million USD | 76.278% |
| UFP Technologies, Inc. | 112.22 Million USD | 8.142% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -823352.352% |
| Tenon Medical, Inc. | 1.24 Million USD | -8206.849% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 127369.136% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -3824.039% |
| AdaptHealth Corp. | 479.56 Million USD | 78.504% |
| Sintx Technologies, Inc. | 1.84 Million USD | -5493.489% |
| NanoVibronix, Inc. | 1.53 Million USD | -6607.092% |
| Quanterix Corporation | 70.64 Million USD | -45.922% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 25491.133% |
| Sensus Healthcare, Inc. | 14.06 Million USD | -633.201% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | -95.316% |
| TransMedics Group, Inc. | 154.09 Million USD | 33.1% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -2215.024% |
| NeuroMetrix, Inc. | 3.94 Million USD | -2511.533% |
| Hyperfine, Inc. | 4.75 Million USD | -2067.08% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 3.635% |
| Biomerica, Inc. | 611 Thousand USD | -16772.013% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | -147.288% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 13300.248% |
| Silk Road Medical, Inc | 127.08 Million USD | 18.883% |